Renal association clinical practice guideline in post-operative care in the kidney transplant recipient

被引:142
作者
Baker, Richard J. [1 ]
Mark, Patrick B. [2 ]
Patel, Rajan K. [2 ]
Stevens, Kate K. [2 ]
Palmer, Nicholas [3 ]
机构
[1] St James Univ Hosp, Renal Unit, Leeds, W Yorkshire, England
[2] Queen Elizabeth Univ Hosp, Glasgow Renal & Transplant Unit, Glasgow, Lanark, Scotland
[3] British Kidney Patient Assoc, Alton, England
关键词
ANTIBODY-MEDIATED REJECTION; DONOR-SPECIFIC ANTIBODIES; NONMELANOMA SKIN-CANCER; BK VIRUS NEPHROPATHY; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; RABBIT ANTITHYMOCYTE GLOBULIN; RANDOMIZED CONTROLLED-TRIAL; SQUAMOUS-CELL CARCINOMA; INDUCED PAIN SYNDROME; BONE-MINERAL DENSITY;
D O I
10.1186/s12882-017-0553-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
These guidelines cover the care of patients from the period following kidney transplantation until the transplant is no longer working or the patient dies. During the early phase prevention of acute rejection and infection are the priority. After around 3-6 months, the priorities change to preservation of transplant function and avoiding the long-term complications of immunosuppressive medication (the medication used to suppress the immune system to prevent rejection). The topics discussed include organization of outpatient follow up, immunosuppressive medication, treatment of acute and chronic rejection, and prevention of complications. The potential complications discussed include heart disease, infection, cancer, bone disease and blood disorders. There is also a section on contraception and reproductive issues. Immediately after the introduction there is a statement of all the recommendations. These recommendations are written in a language that we think should be understandable by many patients, relatives, carers and other interested people. Consequently we have not reworded or restated them in this lay summary. They are graded 1 or 2 depending on the strength of the recommendation by the authors, and AD depending on the quality of the evidence that the recommendation is based on.
引用
收藏
页数:41
相关论文
共 229 条
[1]   New-onset gout after kidney transplantation: Incidence, risk factors and implications [J].
Abbott, KC ;
Kimmel, PL ;
Dharnidharka, V ;
Oglesby, RJ ;
Agodoa, LY ;
Caillard, S .
TRANSPLANTATION, 2005, 80 (10) :1383-1391
[2]   Epstein-Barr Virus and Posttransplant Lymphoproliferative Disorder in Solid Organ Transplant Recipients [J].
Allen, U. ;
Preiksaitis, J. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 :S87-S96
[3]   Proteinuria after kidney transplantation, relationship to allograft histology and survival [J].
Amer, H. ;
Fidler, M. E. ;
Myslak, M. ;
Morales, P. ;
Kremers, W. K. ;
Larson, T. S. ;
Stegall, M. D. ;
Cosio, F. G. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (12) :2748-2756
[4]   Urine High and Low Molecular Weight Proteins One-Year Post-Kidney Transplant: Relationship to Histology and Graft Survival [J].
Amer, H. ;
Lieske, J. C. ;
Rule, A. D. ;
Kremers, W. K. ;
Larson, T. S. ;
Palacios, C. R. Franco ;
Stegall, M. D. ;
Cosio, F. G. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (03) :676-684
[5]   Significance and Management of Proteinuria in Kidney Transplant Recipients [J].
Amer, Hatem ;
Cosio, Fernando G. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (12) :2490-2492
[6]   Reviewing the Evidence for Mycophenolate Mofetil as a New Teratogen: Case Report and Review of the Literature [J].
Anderka, Marlene T. ;
Lin, Angela E. ;
Abuelo, Dianne N. ;
Mitchell, Allen A. ;
Rasmussen, Sonja A. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2009, 149A (06) :1241-1248
[7]  
[Anonymous], 2015, MYC MOF MYC AC NEW P
[8]  
[Anonymous], 2011, NUL BEL RISK EV MIT
[9]  
[Anonymous], 2014, NHS CANC SCREEN PROG
[10]  
[Anonymous], COCHRANE DATABASE SY